- |||||||||| Journal: Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity. (Pubmed Central) - Feb 28, 2024
In comparison, two prototypical particulate ?-glucans, one isolated from I. obliquus and one from Saccharomyces cerevisiae (zymosan), are agonists for Dectin-1 but not TLR2 or TLR4, and are unable to trigger anti-cancer functions of macrophages. We conclude that the water-soluble polysaccharides AcF1 and AcF3 from I. obliquus have a strong potential for cancer immunotherapy by triggering multiple PRRs and by inducing potent anti-cancer activity of macrophages.
- |||||||||| Journal: Self-recognition through Dectin-1 exacerbates liver inflammation. (Pubmed Central) - Feb 22, 2024
These results highlight a role of self-recognition through Dectin-1 that triggers hepatic innate immune responses and contributes to the exacerbation of inflammation in pathogenic settings. Thus, the blockade of this axis may provide a therapeutic option for liver inflammatory diseases.
- |||||||||| Journal: Immunogenetics associated with severe coccidioidomycosis. (Pubmed Central) - Sep 29, 2022
Patients with DCM have impaired β-glucan sensing or response affecting TNF-α and H2O2 production. Impaired Coccidioides recognition and decreased cellular response are associated with disseminated coccidioidomycosis.
- |||||||||| Analysis of Dectin-1 expression and its impact on recurrence in nasal polyp (Room E1, Channel 3) - Apr 30, 2022 - Abstract #EAACI2022EAACI_427;
The patients who had a relapse of CRSwNP showed significantly lower expression of Dectin-1 mRNA in NP than those without recurrence. Conclusion Taken altogether, the expression of Dectin-1 can be utilized as a predictive factor for the recurrence of NP, and the role of Dectin-1 agonist as a therapeutic agent can be considered.
|